The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma.
 
Jennifer Ann Wargo
Honoraria - Dava Oncology; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Genentech; GlaxoSmithKline
Speakers' Bureau - Dava Oncology
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche Pharma AG
 
Rodabe Navroze Amaria
Research Funding - GlaxoSmithKline (Inst)
 
Merrick I. Ross
Honoraria - Amgen; GlaxoSmithKline; Merck
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Merck
Speakers' Bureau - Merck; neostem
Travel, Accommodations, Expenses - Amgen; GlaxoSmithKline; Merck
 
Robyn P.M. Saw
No Relationships to Disclose
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Castle Biosciences; Merck; Navidea
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Genentech/Roche; MD Anderson Cancer Center
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
 
Isabella Claudia Glitza
No Relationships to Disclose
 
Adi Diab
No Relationships to Disclose
 
Richard Kefford
No Relationships to Disclose
 
Richard A Scolyer
No Relationships to Disclose
 
Helen Rizos
No Relationships to Disclose
 
John F Thompson
No Relationships to Disclose
 
Kerwin Shannon
No Relationships to Disclose
 
Andrew Spillane
No Relationships to Disclose
 
Matteo S. Carlino
No Relationships to Disclose
 
Alex Guminski
No Relationships to Disclose
 
Lauren Simpson
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech